Another Delaware Publicly Traded Company Proposes A Nevada Move
JD Supra: Mergers
SEPTEMBER 17, 2024
Last week, Chromocell Therapeutics Corporation filed preliminary proxy materials that included a proposal to reincorporate in Nevada. Rather than convert, the company is proposing to effect the reincorporation by means of a merger with and into a wholly-owned subsidiary of the Company.
Let's personalize your content